Q2 2025 Management View CEO Raul Vazquez highlighted, "Q2 was another strong quarter. GAAP profitability, improved credit ...

The comparative note from PFRDA outlines the structural and functional differences between NPS and EPFO, without prescribing ...

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its ...

Key Points MetLife's adjusted earnings per share (Non-GAAP) fell to $2.02, missed estimates by 6.0% (non-GAAP) and declining 11% from the prior year (non-GAAP, Q2 2025 vs. Q2 2024). Revenue (GAAP) was ...

These 10 stocks could mint the next wave of millionaires › Corteva (NYSE:CTVA), an agriculture technology company specializing in seeds and crop protection products, posted its earnings for the second ...

Q3 2025 Management View CEO Nicholas Lahanas highlighted "a solid third quarter, driven by strong cross-functional collaboration, disciplined execution and the unwavering dedication of team Central ...